Home The History of Synthetic Biology Designing Synthetic Biotics Pipeline Our People Leadership Board of Directors Founders and Advisors Investors + Media Company Overview News News Releases In the News Events & Presentations Events Presentations Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds Synlogic to Present at Upcoming Virtual Banking and Industry Conferences Read more about Synlogic to Present at Upcoming Virtual Banking and Industry Conferences Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors Read more about Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research Laboratory Read more about Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research Laboratory Synlogic Outlines Upcoming Clinical Milestones Read more about Synlogic Outlines Upcoming Clinical Milestones Synlogic Announces Advancement of SYNB1891 to Combination Arm Dosing with PD-L1 Checkpoint Inhibitor in the on-going Phase 1 Study for the Treatment of Solid Tumors and Lymphoma Read more about Synlogic Announces Advancement of SYNB1891 to Combination Arm Dosing with PD-L1 Checkpoint Inhibitor in the on-going Phase 1 Study for the Treatment of Solid Tumors and Lymphoma Synlogic Appoints Michael Heffernan to its Board of Directors Read more about Synlogic Appoints Michael Heffernan to its Board of Directors Synlogic Presents SYNB8802 for Enteric Hyperoxaluria at the American Institute of Chemical Engineers Conference on Microbiome Engineering Read more about Synlogic Presents SYNB8802 for Enteric Hyperoxaluria at the American Institute of Chemical Engineers Conference on Microbiome Engineering Synlogic to Present at Upcoming Virtual Banking Conference Read more about Synlogic to Present at Upcoming Virtual Banking Conference Synlogic Reports Third Quarter 2020 Financial Results and Provides Business Update Read more about Synlogic Reports Third Quarter 2020 Financial Results and Provides Business Update Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria Read more about Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria Pagination First page « First Previous page ‹ Previous … Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Page 14 Page 15 … Next page Next › Last page Last » Subscribe to Investor Resources Contact IR Investor FAQs RSS Feeds Investor Email Alerts Email
Synlogic to Present at Upcoming Virtual Banking and Industry Conferences Read more about Synlogic to Present at Upcoming Virtual Banking and Industry Conferences
Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors Read more about Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors
Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research Laboratory Read more about Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research Laboratory
Synlogic Outlines Upcoming Clinical Milestones Read more about Synlogic Outlines Upcoming Clinical Milestones
Synlogic Announces Advancement of SYNB1891 to Combination Arm Dosing with PD-L1 Checkpoint Inhibitor in the on-going Phase 1 Study for the Treatment of Solid Tumors and Lymphoma Read more about Synlogic Announces Advancement of SYNB1891 to Combination Arm Dosing with PD-L1 Checkpoint Inhibitor in the on-going Phase 1 Study for the Treatment of Solid Tumors and Lymphoma
Synlogic Appoints Michael Heffernan to its Board of Directors Read more about Synlogic Appoints Michael Heffernan to its Board of Directors
Synlogic Presents SYNB8802 for Enteric Hyperoxaluria at the American Institute of Chemical Engineers Conference on Microbiome Engineering Read more about Synlogic Presents SYNB8802 for Enteric Hyperoxaluria at the American Institute of Chemical Engineers Conference on Microbiome Engineering
Synlogic to Present at Upcoming Virtual Banking Conference Read more about Synlogic to Present at Upcoming Virtual Banking Conference
Synlogic Reports Third Quarter 2020 Financial Results and Provides Business Update Read more about Synlogic Reports Third Quarter 2020 Financial Results and Provides Business Update
Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria Read more about Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria